Plasmodium berghei: Analysis of the γ-glutamylcysteine synthetase gene in drug-resistant lines

Experimental Parasitology

Volumn 101, Issue 4, 2002, Pages 175-182

  Pérez Rosado, José ^a   Gervais, Gary W ^a   Ferrer Rodríguez, Iván ^a   Peters, Wallace ^b   Serrano, Adelfa E ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; GLUTAMATE CYSTEINE LIGASE; MEFLOQUINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; GENE LOCUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 0036707351     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4894(02)00138-8     Document Type: Article

References (65)

1. Altschul S.F., Gish W., Miller W., Myer E.W., Lipman D.L. Basic local alignment search tool. Journal of Molecular Biology. 215:1990;403-410.
2. Baggaley V.C., Atkinson E.M. Use of CF12 columns for preparation of DNA from rodent malarias. Transactions of the Royal Society of Tropical Medicine and Hygiene. 66:1972;4-5.
3. Bailey H.H., Gipp J.J., Ripple M., Wilding G., Mulcahy R.T. Increase in. γ -glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels Cancer Research. 52:1992;5115-5118.
4. Barker R.H., Suebsaeng L., Rooney W., Alecrim G.C., Dourado H.V., Wirth D.F. Specific DNA probe for the diagnosis of Plasmodium falciparum malaria. Science. 231:1986;1434-1436.
5. Bhatia A., Charet P. Chloroquine induces oxidative lysis of Plasmodium berghei parasitized red blood cells. Annals Societe Belge Médica Tropicale. 65:1985;97-103.
6. Birago C., Pace T., Picci L., Picci E., Scotti R., Ponzi M. The putative gene for the first enzyme of glutathione biosynthesis in Plasmodium berghei and Plasmodium falciparum. Molecular and Biochemical Parasitology. 99:1999;33-40.
7. Cheng Q., Saul A. The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance. Molecular and Biochemical Parasitology. 65:1994;361-363.
8. Chomcynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Analytical Biochemistry. 162:1987;156-159.
9. Cowman A.F., Galatis D., Thompson J.K. Selection of mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proceedings of the National Academic Sciences of the United States of America. 91:1994;1143-1147.
10. Cowman A.F., Lew A.M. Chromosomal rearrangements and point mutations in the DHFR-TS gene of Plasmodium chabaudi under antifolate selection. Molecular and Biochemical Parasitology. 42:1990;21-30.
11. Dubois V.L., Platel D.F.N., Pauly G., Tribouley-Duret J. Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Experimental Parasitology. 81:1995;117-124.
12. Famin O., Krugliak M., Ginsburg H. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. Biochemical Pharmacology. 58:1999;59-68.
13. Fidock A.D., Nomura T., Talley K.A., Cooper A.R., Dzekunov M.S., Ferdig T.M., Ursos M.L., Sidhu A.B., Naude B., Deitsch W.K., Su Z.X., Wootton C.J., Roepe D.P., Wellems E.T. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell. 6:2000;861-871.
14. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum Analytical Biochemistry. 137:1984;266-267.
15. Fitch C.D., Chevli R., Banyal H.S., Phillips J., Pfaller G.W., Krogstad D.J. Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex. Antimicrobial Agents and Chemotherapy. 21:1982;819-822.
16. Foote S.J., Thompson J.K., Cowman A.F., Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant Isolates of P. falciparum. Cell. 57:1989;920-930.
17. Foote S.J., Kyle D.E., Martin R.K., Oduolla A.M.J., Forsyth K., Kemp D.J., Cowman A.F. Several alleles of the multidrug resistance gene are closely linked to chloroquine in Plasmodium falciparum. Nature. 345:1990;255-258.
18. Gervais G., Trujillo K., Robinson B.L., Peters W., Serrano A.E. Plasmodium berghei: identification of an mdr like gene associated with drug resistance. Experimental Parasitology. 91:1999;86-92.
19. Ginsburg H., Famin O., Zhang J., Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochemical Pharmacology. 56:1998;1305-1313.
20. Ginsburg H., Ward S.A., Bray P.G. An integrated model of chloroquine action. Parasitology Today. 15:1999;357-360.
21. Godwin A.K., Meister A., O'Dwyer P.J., Huang C.S., Hamilton T.V., Anderson M.E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked of glutathione levels. Proceedings of the National Academy of Sciences of the United States of America. 89:1992;3070-3074.
22. Grech K.V., Davey R.A., Davey M.W. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells. Biochemical Pharmacology. 55:1998;1283-1289.
23. Griffith O.W. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radical Biology and Medicine. 27:1999;922-935.
24. Grondin K., Papadopoulou B., Ouellete M. Homologous recombination between direct repeat sequences yields P-glycoprotein containing circular amplicons in arsenite-resistant Leishmania. Nucleic Acids Research. 21:1993;1895-1901.
25. Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., Ouellete M. Co-amplification of the glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. The EMBO Journal. 16:1997;3057-3065.
26. Haimeur A., Brochu C., Genest P.A., Papadopoulou B., Ouellete M. Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII)-resistant Leishmania tarentolae. Molecular and Biochemical Parasitology. 108:2000;131-135.
27. Korsinczky M., Chen N., Kotecka B., Saul A., Rieckmann K., Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrobial Agents and Chemotherapy. 44:2000;2100-2108.
28. Krogstad D.J., Gluzman I.Y., Ling V. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science. 238:1987;1283-1285.
29. Lee T.C., Wei M.L., Chang W.J., Ho I.C., Lo J.F., Jan K.Y., Huang H. Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant chinese hamster ovary cells in vitro. Cell and Developmental Biology. 24:1989;442-448.
30. Loria P., Miller S., Foley M., Tilley L. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochemical Journal. 339:1999;363-370.
31. Luersen K., Walter R.D., Mueller S. The putative. γ -glutamylcysteine synthetase from Plasmodium falciparum contains large insertions and a variable tandem repeat Molecular and Biochemical Parasitology. 98:1999;131-142.
32. Macomber P.B., O'brian R.L., Hahn F.E. Chloroquine: physiological basis of drug resistance in Plasmodium berghei. Science. 152:1966;1365-1372.
33. Martin S.K., Odula A.M.J., Milhous W.K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 235:1987;899-901.
34. Meierjohann S., Walter R.D., Mueller S. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine sensitive and chloroquine resistant Plasmodium falciparum. Biochemical Journal. 368:2002;761-768.
35. Ndifor A.M., Ward S.A., Howels R.E. Cytochrome P-450 activity in malarial parasites and its possible relationship to chloroquine resistance. Molecular and Biochemical Parasitology. 41:1990;251-258.
36. Peel S.A., Bright P., Yount B., Handy J., Baric R.S. A strong association between mefloquine and halofantrine resistance and amplification, overexpression and mutations in the P-glycoprotein gene homolog (pfmdr1) of Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene. 51:1994;648-658.
37. Peters W. Drug resistance in Plasmodium berghei, Vincke and Lips, 1948. I. Chloroquine resistance. Experimental Parasitology. 17:1965;89-90.
38. Peters W. Chemotherapy and Drug Resistance in Malaria. vol. I:1987;440-451 Academic Press, London.
39. Peters W., Portus J.H., Robinson B.L. The chemotherapy of rodent malaria. XXII. The value of drug-resistant strains of P. berghei in screening for blood schinzonticidal activity. Annals of Tropical Medicine and Parasitology. 69:1975;155-171.
40. Peters W., Portus J.H., Robinson B.L. The chemotherapy of rodent malaria. XXVIII. The development of resistance to mefloquine (WR 142,490). Annals of Tropical Medicine and Parasitology. 71:1977;419-427.
41. Peters W., Robinson B.L. The chemotherapy of rodent malaria. XLVII. Studies on pyronaridine and other Mannich base antimalarials. Annals of Tropical Medicine and Parasitology. 86:1992;455-465.
42. Peterson D.S., Walliker D., Wellems T.E. Evidence that a point mutation in dehydrofolate reductase-thymidylate synthetase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy Sciences of the United States of the America. 85:1988;9114-9118.
43. Platel D.F.N., Mangou F., Tribouley-Duret J. Role of glutathione in the detoxification of ferriprotoporphyrin IX in chloroquine-resistant Plasmodium berghei. Molecular and Biochemical Parasitology. 98:1999;215-223.
44. Sanchez C.P., Wunsch S., Lanzer M. Identification of a chloroquine importer in Plasmodium falciparum. Journal of Biological Chemistry. 272:1997;2652-2658.
45. Sanderson A., Walliker D., Molez J. Enzyme typing of Plasmodium falciparum from African and some other Old World countries. Transactions of the Royal Society of Tropical Medicine and Hygiene. 75:1981;263-267.
46. Scheibel W., Miller J. Cytochrome oxidase activity in platelet-free preparations of Plasmodium knowlesi. Journal of Parasitology. 55:1969;825-829.
47. Seelig G.F., Meister A. Glutathione biosynthesis: γ -glutamylcysteine synthetase from rat kidney Methods in Enzymology. 113:1985;279-290.
48. Serrano A.E., Robinson B.L., Peters W., Trujillo-Nevarez K. Plasmodium berghei and Plasmodium yoelii: molecular karyotypes of drug-resistant lines. Experimental Parasitology. 91:1999;93-96.
49. Skapek S.X., Colvin O.M., Friedman H.S. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Cancer Research. 48:1988;2764-2767.
50. Srivastava I.K., Morrisey J.M., Darrouzet E., Daldal F., Vaidya A.B. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Molecular Microbiology. 33:1999;704-711.
51. Srivastava P., Pandey V.C. Heme oxygenase and related indices in chloroquine-resistant and -sensitive strains of Plasmodium berghei. International Journal of Parasitology. 25:1995;1061-1064.
52. Srivastava P., Puri S.K., Kamboj K.K., Pandey V.C. Glutathione S-transferase activity in malarial parasites. Tropical Medicine and International Health. 4:1999;251-254.
53. Syafruddin D., Siregar J.E., Marzuki S. Resistance mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone. Molecular and Biochemical Parasitology. 104:1999;185-194.
54. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Research. 54:1994;4313-4320.
55. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research. 22:1994;4673-4680.
56. Triglia T., Wang P., Sims P.F., Hyde J.E., Cowman A.F. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. The EMBO Journal. 17:1998;3807-3815.
57. Valecha N., Biswas S., Dewan S., Bhambhani S. Reversal of chloroquine resistance with verapamil in P. berghei in vivo. Indian Journal of Malariology. 29:1992;47-53.
58. van Belkum A., Janse C., Mons B. Nucleotide sequence variation in the. β -tubulin genes from Plasmodium berghei and Plasmodium falciparum Molecular and Biochemical Parasitology. 47:1991;251-254.
59. van Dijk M.R., McConkey G.A., Vinkenoog R., Waters A.P., Janse C.J. Mechanisms of pyrimethamine resistance in two different strains of Plasmodium berghei. Molecular and Biochemical Parasitology. 68:1994;167-171.
60. Wernsdorfer W.H. Epidemiology of drug resistance in malaria. Acta Tropica. 56:1994;143-156.
61. Wilson C.M., Serrano A.E., Wasley A., Bogenshutz M.P., Shankar A.H., Wirth D.F. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science. 244:1989;1184-1186.
62. Wilson C.M., Volkman S.K., Thaithong S., Martin R.K., Kyle D.E., Milhous W.K., Wirth D.F. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Molecular and Biochemical Parasitology. 57:1993;151-160.
63. Wunsch S., Sanchez C.P., Gekle M., Grobe-Wortmann L., Wiesner J., Lanzer M. Differential stimulation of the Na/H exchanger determines chloroquine uptake in Plasmodium falciparum. Journal of Cell Biology. 140:1998;335-345.
64. Yao K.S., Godwin A.K., Johnson S.W., Ozols R.F., O'Dwyer P.J., Hamilton T.C. Evidence for altered regulation of g-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Research. 55:1995;4367-4374.
65. Zhang J., Krugliak M., Ginsburg H. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs. Molecular and Biochemical Parasitology. 99:1999;129-141.